Frederick C. Beddingfield III
2017
In 2017, Frederick C. Beddingfield III earned a total compensation of $2.4M as President and Chief Executive Officer at Sienna Biopharmaceuticals, a 127% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $290,232 |
|---|---|
| Option Awards | $364,147 |
| Salary | $392,273 |
| Other | $1,321,201 |
| Total | $2,367,853 |
Beddingfield received $1.3M in other compensation, accounting for 56% of the total pay in 2017.
Beddingfield also received $290.2K in non-equity incentive plan, $364.1K in option awards and $392.3K in salary.
Rankings
In 2017, Frederick C. Beddingfield III's compensation ranked 4,689th out of 14,666 executives tracked by ExecPay. In other words, Beddingfield earned more than 68.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,689 out of 14,666 | 68th |
Division Manufacturing | 1,651 out of 5,772 | 71st |
Major group Chemicals And Allied Products | 480 out of 2,075 | 77th |
Industry group Drugs | 370 out of 1,731 | 79th |
Industry Pharmaceutical Preparations | 292 out of 1,333 | 78th |
Source: SEC filing on April 19, 2018.
Beddingfield's colleagues
We found four more compensation records of executives who worked with Frederick C. Beddingfield III at Sienna Biopharmaceuticals in 2017.